Clinical characteristics and the diagnostic role of molecular tests in musculoskeletal infections caused by nontuberculous Mycobacterium: a single-center experience
- PMID: 35320503
- DOI: 10.1007/s15010-022-01780-4
Clinical characteristics and the diagnostic role of molecular tests in musculoskeletal infections caused by nontuberculous Mycobacterium: a single-center experience
Abstract
Purpose: We retrospectively investigated NTM musculoskeletal infections to understand the clinical characteristics as well as the diagnostic performance of molecular tests as a useful supplementary test.
Methods: A retrospective cohort study was conducted from January 2016 to December 2019. Intraoperative specimens for culture and pathological analysis were obtained during surgery under sterile conditions. AdvanSure TB/NTM real-time PCR (LG Life Sciences, Seoul, Korea) and PCR-reverse blot hybridization assay (REBA, REBA Myco-ID; YD Diagnostics, Yongin, Republic of Korea) was performed directly from tissue specimens for the rapid and accurate identification of 20 mycobacterial species.
Results: A series of 24 patients was identified during the study period. Agricultural/aquatic exposure were predisposing factors in 9 patients, trauma in 4 patients, but no predisposing host factor was identified for 11 patients. Twenty-two patients presented with tenosynovitis and two with arthritis with substantial delays between initial presentation of symptoms and microbiologic diagnosis, with a median of 147 days (range 5-396 days). Pathologic tissue examination of musculoskeletal NTM infections was positive for chronic granulomatous inflammation in 18 cases. Fifteen were positive in the culture study, and nine were positive only in the molecular study using tissue specimens. All 6 M. ulcerans/M. marinum isolates were identified only by PCR.
Conclusions: This study is an important reminder that NTM infections should be a part of the differential diagnosis in patients with chronic musculoskeletal infections refractory to regular treatment. Although molecular test cannot replace the conventional smear and culture methods, it can be used as a useful supplementary test especially in diagnosing M. marinum infection.
Keywords: Identification; NTM; Nontuberculous mycobacteria; Polymerase chain reaction; Tenosynovitis.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.Microbiol Spectr. 2023 Aug 17;11(4):e0160623. doi: 10.1128/spectrum.01606-23. Epub 2023 Jun 28. Microbiol Spectr. 2023. PMID: 37378523 Free PMC article.
-
PCR-reverse blot hybridization assay in respiratory specimens for rapid detection and differentiation of mycobacteria in HIV-negative population.BMC Infect Dis. 2021 Mar 16;21(1):264. doi: 10.1186/s12879-021-05934-x. BMC Infect Dis. 2021. PMID: 33726688 Free PMC article.
-
Performance Evaluation of MolecuTech REBA Myco-ID Using HybREAD480 for Identification of Nontuberculous Mycobacteria.Clin Lab. 2023 Jul 1;69(7). doi: 10.7754/Clin.Lab.2022.221115. Clin Lab. 2023. PMID: 37436396
-
Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.Future Microbiol. 2015;10(9):1467-83. doi: 10.2217/fmb.15.64. Epub 2015 Sep 7. Future Microbiol. 2015. PMID: 26344005 Review.
-
[Nontuberculous mycobacteria].Hautarzt. 2017 May;68(5):403-411. doi: 10.1007/s00105-017-3970-z. Hautarzt. 2017. PMID: 28331949 Review. German.
References
-
- Brode SK, Marchand-Austin A, Jamieson FB, Marras TK. Pulmonary versus nonpulmonary nontuberculous mycobacteria, Ontario Canada. Emerg Infect Dis. 2017;23:1898–901. https://doi.org/10.3201/eid2311.170959 . - DOI - PubMed - PMC
-
- Henkle E, Hedberg K, Schafer SD, Winthrop KL. Surveillance of extrapulmonary nontuberculous mycobacteria infections, Oregon, USA, 2007–2012. Emerg Infect Dis. 2017;23:1627–30. https://doi.org/10.3201/eid2310.170845 . - DOI - PubMed - PMC
-
- Hermansen TS, Ravn P, Svensson E, Lillebaek T. Nontuberculous mycobacteria in denmark, incidence and clinical importance during the last quarter-century. Sci Rep. 2017;7:6696. https://doi.org/10.1038/s41598-017-06931-4 . - DOI - PubMed - PMC
-
- Ricotta EE, Adjemian J, Blakney RA, Lai YL, Kadri SS, Prevots DR. Extrapulmonary nontuberculous mycobacteria infections in hospitalized patients, United States, 2009–2014. Emerg Infect Dis. 2021;27:845–52. https://doi.org/10.3201/eid2703.201087 . - DOI - PubMed - PMC
-
- Wi YM. Treatment of extrapulmonary nontuberculous mycobacterial diseases. Infect Chemother. 2019;51:245–55. https://doi.org/10.3947/ic.2019.51.3.245 . - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical